Illinois Administrative Code › Title 35 - ENVIRONMENTAL PROTECTION › Part 726 - STANDARDS FOR THE MANAGEMENT OF SPECIFIC HAZARDOUS WASTE AND SPECIFIC TYPES OF HAZARDOUS WASTE MANAGEMENT FACILITIES › Subpart P - HAZARDOUS WASTE PHARMACEUTICALS › Section 726.609 - Shipping to a Reverse Distributor

Current through Register Vol. 48, No. 28, July 12, 2024
a)
				Shipping Potentially Creditable Hazardous Waste Pharmaceuticals. A healthcare
				facility or reverse distributor that transports or offers for transport
				potentially creditable hazardous waste pharmaceuticals offsite to a reverse
				distributor must comply with all applicable USDOT regulations in 49 CFR 171
				through 180, incorporated by reference in 35 Ill. Adm. Code
				720.111, for any
				potentially creditable hazardous waste pharmaceutical that meets the definition
				of hazardous material in
				49 CFR
				171.8, incorporated by reference in 35 Ill.
				Adm. Code 720.111.
BOARD NOTE: For purposes of the USDOT regulations, a material
				  is considered a hazardous waste if it is subject to USEPA's hazardous waste
				  manifest requirements in 40 CFR 262 (corresponding with 35 Ill. Adm. Code 722
				  in Illinois). Because a potentially creditable hazardous waste pharmaceutical
				  does not require a manifest, it is not considered hazardous waste under USDOT
				  regulations.
b) Delivery
				Confirmation. Upon receipt of each shipment of potentially creditable hazardous
				waste pharmaceuticals, the receiving reverse distributor must provide
				confirmation (paper or electronic) to the healthcare facility or reverse
				distributor initiating the shipment that the shipment has arrived at its
				destination and is under the custody and control of the reverse
				distributor.
c) Procedures for When
				Delivery Confirmation is Not Received within 35 Calendar Days. If a healthcare
				facility or reverse distributor initiates a shipment of potentially creditable
				hazardous waste pharmaceuticals to a reverse distributor and does not receive
				delivery confirmation within 35 calendar days after the date when it sent the
				shipment of potentially creditable hazardous waste pharmaceuticals, the
				healthcare facility or reverse distributor that initiated the shipment must
				promptly contact the carrier and the intended recipient (i.e., the reverse
				distributor) to report that it did not receive the delivery confirmation and to
				determine the status of the potentially creditable hazardous waste
				pharmaceuticals.
d) Exporting
				Potentially Creditable Hazardous Waste Pharmaceuticals. A healthcare facility
				or reverse distributor that sends potentially creditable hazardous waste
				pharmaceuticals to a foreign destination must comply with subsections (a)
				through (c) and the applicable requirements of Subpart D of 35 Ill. Adm. Code
				722, except the manifesting requirement of 35 Ill. Adm. Code
				722.183(c).
e) Importing Potentially Creditable Hazardous
				Waste Pharmaceuticals. Any person that imports potentially creditable hazardous
				waste pharmaceuticals into the United States is subject to subsections (a)
				through (c) in lieu of Subpart H of 35 Ill. Adm. Code 722. Immediately after
				the potentially creditable hazardous waste pharmaceuticals enter the United
				States, they are subject to all applicable requirements of this Subpart
				P.